Advertisement

Rheumatology International

, Volume 13, Issue 2, pp 77–82 | Cite as

Detection of tumour necrosis factor alpha and interleukin-1 beta in the rheumatoid osteoarthritic cartilage-pannus junction by immunohistochemical methods

  • V. E. Miller
  • K. Rogers
  • K. D. Muirden
Originals

Summary

During inflammation the rheumatoid synovial membrane is invaded by a number of different cell types. When activated most of these cells produce cytokines including tumor necrosis factor alpha (TNFα) and interleukin-1 beta (IL-1 β). These cytoiines are believed to stimulate production of degradative enzymes and disturb the equilibrium between such enzymes and their inhibitors resulting in tissue damage. In this study we investigated the localisation of TNFα and IL-1 β at the cartilage-pannus junction (CPJ). Here, cytokines are well placed to influence the integrity of articular cartilage. Tissue was derived from advanced rheumatoid (RA) and, as a comparison, osteoarthritic (OA) joints at the time of replacement surgery (arthroplasty). Antibody staining of fixed serial sections of tissue localised cells that were associated with IL-1 β and TNFα. Cell markers for macrophages and endothelial cells were included to provide positive identification of the cytokine-associated cells. Analysis of these sections revealed that both TNFα and IL-1 β were associated with macrophages, particularly those in the synovium overlying cartilage (pannus) and endothelial cells. Positive staining was seen at the CPJ in RA and in similarly located tissue in OA. The similar distribution of cytokines in OA was unexpected even if the overall numbers of tissue and infiltrating cells in the CPJ were different in the two diseases. This highlights the possible role played by endogenous inhibitors [1, 2] in influencing the degree of cytokine activity necessary to explain the different pathogenic mechanisms in RA and OA.

Key words

Rheumatoid arthritis Interleukin-1-β Tumour necrosis factor α Synovial membrane Immunohistochemistry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dayer J-M (1991) Chronic inflammatory joint diseases: natural inhibitors of interleukin-1 and tumor necrosis factor alpha. J Rheumatol 18 [Supp 27]:71–75Google Scholar
  2. 2.
    Arend WP, Dayer J-M (1990) Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33:305–315Google Scholar
  3. 3.
    Muirden KD, Valkenburg HA (1991) COPCORD in Australian urban and rural populations. Aust N Z J Med 21 [Suppl 1]:194Google Scholar
  4. 4.
    Allard SA, Bayliss MT, Maini RM (1990) The synovium-cartilage junction of the normal human knee. Arthritis Rheum 33:1170–1178Google Scholar
  5. 5.
    Harris ED (1976) Recent insights into the pathogenesis of the proliferative lesion of rheumatoid arthritis. Arthritis Rheum 19:68–72Google Scholar
  6. 6.
    Revell PA, Mayston V, Lalor P, Mapp P (1988) The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthiris using monoclonal antibodies. Ann Rheum Dis 47:300–307Google Scholar
  7. 7.
    Dingle JT (1991) Cartilage maintenance in osteoarthritis: interaction of cytokines, NSAIDs and prostaglandins in articular cartilage and repair. J Rheumatol 18:30–37Google Scholar
  8. 8.
    Miossec P, Ziff M (1986) Immune interferon enhances the production of interleukin-1 by human endothelial cells stimulated with lipopolysaccharide. J Immunol 137:2848–2852Google Scholar
  9. 9.
    Wilkinson LS, Edwards JCW (1991) Binding of antibodies raised against umor necrosis factor alpha (TNFα) to blood vessels and macrophages in inflamed synovial tissue. Rheumatol Int 11:19–25Google Scholar
  10. 10.
    Warner S, Libby P (1989) Human vascular smooth muscle cells: target for and source of tumour necrosis factor. J Immunol 142:100–109Google Scholar
  11. 11.
    Rath NC, Oronsky AL (1988) Synthesis of interleukin-1-like activity by normal rat chondrocytes in culture. Clin Immunol Immunopathol 49:39–46Google Scholar
  12. 12.
    Lee J, Vilcek J (1987) Biology of disease. Tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest 56:234–248Google Scholar
  13. 13.
    Lipsky P, Davis LS, Cush JJ, Oppenheimer-Marks N (1989) The role of cytokines in the pathogenesis or rheumatoid arthritis. Springer Semin Immunopathol 11:123–162Google Scholar
  14. 14.
    Saklatvala J, Guesdon F (1992) Interleukin-1 and tumor necrosis factor signal transduction mechanisms: potential targets for pharmacological control of inflammation. J Rheumatol [Suppl 3]2:65–69Google Scholar
  15. 15.
    Kirkham B (1991) Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 50:395–400Google Scholar
  16. 16.
    Pelletier J-P, Faure M-P, McCollum R, Coutier J-M, Martel-Pelletier J (1990) Synthesis and role of IL-1 and TNF-α in human osteoarthritic (OA) joints. Arthritis Rheum 33 [Suppl]:S 31Google Scholar
  17. 17.
    Cordell JL, Falini B, Erber WN (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219–229Google Scholar
  18. 18.
    Scopsi L, Larsson LI (1986) Increased sensitivity in peroxidase immunocytochemistry. A comparative study of a number of peroxidase visualisation methods employing a model system. Histochemistry 84:221–230Google Scholar
  19. 19.
    Chu CQ, Field M, Feldmann M, Maini RN (1991) Localisation of tumour necrosis factor alpha in synovial tissues and at the cartilage-pannus-junction in patients with rheumatoid arthritis. Arthritis Rheum 34:1125–1132Google Scholar
  20. 20.
    Bucala R, Ritchlin C, Winchester R, Cerami A (1991) Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 173:569–574Google Scholar
  21. 21.
    Husby G, Williams RC Jr (1988) Synovial localisation of tumour necrosis factor in patients with rheumatoid arthritis. J Autoimmun 1:363–371Google Scholar
  22. 22.
    Miossec P, Cavender D, Ziff M (1986) Production of interleukin-1 by human endothelial cells. J Immunol 136:2486–2491Google Scholar
  23. 23.
    Haraou B, Pelletier J-P, Cloutier J-M, Faure MP, Martel-Pelletier J (1991) Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 34:153–163Google Scholar
  24. 24.
    Brennan FM, Chantry D, Jackson AM, Maini RN, Feldman M (1989) Cytokine production in culture by cells isolated from synovial membrane. J Autoimmun 2[Suppl]:177–186Google Scholar
  25. 25.
    Ismaiel S, Atkins RM, Pearse MF, Dieppe PA, Elson CJ (1992) Susceptibility of normal and arthritic human articular cartilage to degradative stimuli. Br J Rheumatol 31:369–373Google Scholar
  26. 26.
    Pelletier J-P, Roughley PJ, DiBattista JA, McCollum R, Martell-Pelletier J (1991) Are cytokines involved in osteoarthritic pathophysiology? Semin Arthritis Rheum 20 [Suppl 2]:12–25Google Scholar
  27. 27.
    Feldmann M, Brennan FM, Chantry D, Haworth C, Turner M, Abney E, Buchan G, Barret K, Barley D, Chu A, Field M, Maini RN (1990) Cytokine production in the rheumatoid joint: implications for treatment. Ann Rheum Dis 49:480–486Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • V. E. Miller
    • 1
  • K. Rogers
    • 1
  • K. D. Muirden
    • 1
  1. 1.Department of Medicine, The Royal Melbourne HospitalUniversity of MelbourneAustralia

Personalised recommendations